Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SRRM4 Expression and the Loss of REST Activity May Promote the Emergence of the Neuroendocrine Phenotype in Castration-Resistant Prostate Cancer
Xiaotun Zhang, Ilsa M. Coleman, Lisha G. Brown, et al.
Clinical Cancer Research (2015) Vol. 21, Iss. 20, pp. 4698-4708
Open Access | Times Cited: 167

Showing 1-25 of 167 citing articles:

Patient-derived xenografts undergo mouse-specific tumor evolution
Uri Ben‐David, Gavin Ha, Yuen‐Yi Tseng, et al.
Nature Genetics (2017) Vol. 49, Iss. 11, pp. 1567-1575
Open Access | Times Cited: 638
The Master Neural Transcription Factor BRN2 Is an Androgen Receptor–Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer
Jennifer L. Bishop, Daksh Thaper, Sepideh Vahid, et al.
Cancer Discovery (2016) Vol. 7, Iss. 1, pp. 54-71
Open Access | Times Cited: 372
Cellular plasticity and the neuroendocrine phenotype in prostate cancer
Alastair Davies, Himisha Beltran, Amina Zoubeidi
Nature Reviews Urology (2018) Vol. 15, Iss. 5, pp. 271-286
Closed Access | Times Cited: 355
Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer
Mark P. Labrecque, Ilsa M. Coleman, Lisha G. Brown, et al.
Journal of Clinical Investigation (2019) Vol. 129, Iss. 10, pp. 4492-4505
Open Access | Times Cited: 346
The Role of Lineage Plasticity in Prostate Cancer Therapy Resistance
Himisha Beltran, Andrew M. Hruszkewycz, Howard I. Scher, et al.
Clinical Cancer Research (2019) Vol. 25, Iss. 23, pp. 6916-6924
Open Access | Times Cited: 296
LuCaP Prostate Cancer Patient-Derived Xenografts Reflect the Molecular Heterogeneity of Advanced Disease an­­d Serve as Models for Evaluating Cancer Therapeutics
Holly M. Nguyen, Robert L. Vessella, Colm Morrissey, et al.
The Prostate (2017) Vol. 77, Iss. 6, pp. 654-671
Open Access | Times Cited: 274
Inter- and intra-tumor heterogeneity of metastatic prostate cancer determined by digital spatial gene expression profiling
Lauren Brady, Michelle Kriner, Ilsa M. Coleman, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 225
Clinical and Biological Features of Neuroendocrine Prostate Cancer
Yasutaka Yamada, Himisha Beltran
Current Oncology Reports (2021) Vol. 23, Iss. 2
Open Access | Times Cited: 191
Androgen deprivation promotes neuroendocrine differentiation and angiogenesis through CREB-EZH2-TSP1 pathway in prostate cancers
Yan Zhang, Dayong Zheng, Ting Zhou, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 179
Emerging Variants of Castration-Resistant Prostate Cancer
Panagiotis J. Vlachostergios, Loredana Puca, Himisha Beltran
Current Oncology Reports (2017) Vol. 19, Iss. 5
Open Access | Times Cited: 176
N-Myc–mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer
Adeline Berger, Nicholas J. Brady, Rohan Bareja, et al.
Journal of Clinical Investigation (2019) Vol. 129, Iss. 9, pp. 3924-3940
Open Access | Times Cited: 159
Epigenetic modulations and lineage plasticity in advanced prostate cancer
Rongrong Ge, Zifan Wang, Rodolfo Montironi, et al.
Annals of Oncology (2020) Vol. 31, Iss. 4, pp. 470-479
Open Access | Times Cited: 155
Application of Prostate Cancer Models for Preclinical Study: Advantages and Limitations of Cell Lines, Patient-Derived Xenografts, and Three-Dimensional Culture of Patient-Derived Cells
Takeshi Namekawa, Kazuhiro Ikeda, Kuniko Horie‐Inoue, et al.
Cells (2019) Vol. 8, Iss. 1, pp. 74-74
Open Access | Times Cited: 151
Pan-cancer Convergence to a Small-Cell Neuroendocrine Phenotype that Shares Susceptibilities with Hematological Malignancies
Nikolas G. Balanis, Katherine M. Sheu, Favour N. Esedebe, et al.
Cancer Cell (2019) Vol. 36, Iss. 1, pp. 17-34.e7
Open Access | Times Cited: 146
Molecular events in neuroendocrine prostate cancer development
Yong Wang, Yu Wang, Xinpei Ci, et al.
Nature Reviews Urology (2021) Vol. 18, Iss. 10, pp. 581-596
Open Access | Times Cited: 121
FOXA2 drives lineage plasticity and KIT pathway activation in neuroendocrine prostate cancer
Ming Han, Fei Li, Yehan Zhang, et al.
Cancer Cell (2022) Vol. 40, Iss. 11, pp. 1306-1323.e8
Open Access | Times Cited: 92
Ectopic JAK–STAT activation enables the transition to a stem-like and multilineage state conferring AR-targeted therapy resistance
Su Deng, Choushi Wang, Yunguan Wang, et al.
Nature Cancer (2022) Vol. 3, Iss. 9, pp. 1071-1087
Open Access | Times Cited: 87
Aggressive variants of prostate cancer: underlying mechanisms of neuroendocrine transdifferentiation
Lina Merkens, Verena Sailer, Davor Lessel, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 84
Macrophages promote anti-androgen resistance in prostate cancer bone disease
Xue-Feng Li, Çiğdem Selli, Hanlin Zhou, et al.
The Journal of Experimental Medicine (2023) Vol. 220, Iss. 4
Open Access | Times Cited: 41
SRRM4 Drives Neuroendocrine Transdifferentiation of Prostate Adenocarcinoma Under Androgen Receptor Pathway Inhibition
Yinan Li, Nilgun Donmez, Cenk Sahinalp, et al.
European Urology (2016) Vol. 71, Iss. 1, pp. 68-78
Closed Access | Times Cited: 163
FOXA1 inhibits prostate cancer neuroendocrine differentiation
Jung Kim, Hongjian Jin, Jonathan C. Zhao, et al.
Oncogene (2017) Vol. 36, Iss. 28, pp. 4072-4080
Open Access | Times Cited: 134
Systemic surfaceome profiling identifies target antigens for immune-based therapy in subtypes of advanced prostate cancer
John K. Lee, Nathanael J. Bangayan, Timothy Chai, et al.
Proceedings of the National Academy of Sciences (2018) Vol. 115, Iss. 19
Open Access | Times Cited: 127
Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticity
Joanna Cyrta, Anke Augspach, Maria Rosaria De Filippo, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 112
The Role of Epigenetics and Long Noncoding RNA MIAT in Neuroendocrine Prostate Cancer
Francesco Crea, Erik Venalainen, Xinpei Ci, et al.
Epigenomics (2016) Vol. 8, Iss. 5, pp. 721-731
Open Access | Times Cited: 105
Neuroendocrine Differentiation in Prostate Cancer: Emerging Biology, Models, and Therapies
Loredana Puca, Panagiotis J. Vlachostergios, Himisha Beltran
Cold Spring Harbor Perspectives in Medicine (2018) Vol. 9, Iss. 2, pp. a030593-a030593
Open Access | Times Cited: 101
Page 1 - Next Page

Scroll to top